| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1009434836 |
| P356 | DOI | 10.1186/1743-7075-10-40 |
| P932 | PMC publication ID | 3680329 |
| P698 | PubMed publication ID | 23718875 |
| P5875 | ResearchGate publication ID | 236967113 |
| P2093 | author name string | Harsh Patel | |
| Jorge Bolinaga | |||
| Nathania Soekamto | |||
| Srinidi Mohan | |||
| P2860 | cites work | Effects of chronic treatment with L-arginine on atherosclerosis in apoE knockout and apoE/inducible NO synthase double-knockout mice | Q44275935 |
| Effect of L-arginine on intestinal mucosal immune barrier function in weaned pigs after Escherichia coli LPS challenge | Q44660012 | ||
| Soluble guanylyl cyclase activator YC-1 inhibits human neutrophil functions through a cGMP-independent but cAMP-dependent pathway | Q44674231 | ||
| L-arginine supplementation in peripheral arterial disease: no benefit and possible harm | Q44701501 | ||
| A pilot study of L-arginine supplementation on functional capacity in peripheral arterial disease. | Q44907812 | ||
| Effects of arginine supplementation on mucosal immunity in rats with septic peritonitis | Q45008923 | ||
| Efficacy and safety of oral l-arginine in acute myocardial infarction. Results of the multicenter, randomized, double-blind, placebo-controlled ARAMI pilot trial. | Q46521221 | ||
| Bradykinin stimulates endothelial cell fatty acid oxidation by CaMKK-dependent activation of AMPK. | Q46810678 | ||
| Atrial natriuretic peptide-initiated cGMP pathways regulate vasodilator-stimulated phosphoprotein phosphorylation and angiogenesis in vascular endothelium | Q46851046 | ||
| L-arginine therapy in acute myocardial infarction: the Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial | Q46878007 | ||
| Role of nitric oxide in NMDA-evoked release of [3H]-dopamine from striatal slices | Q48482563 | ||
| Correction of endothelial dysfunction in chronic heart failure: additional effects of exercise training and oral L-arginine supplementation | Q49065954 | ||
| Nutritional therapy for peripheral arterial disease: a double-blind, placebo-controlled, randomized trial of HeartBar. | Q53914942 | ||
| Fluid Shear Stress and NO Decrease the Activity of the Hydroxy-Methylglutaryl Coenzyme A Reductase in Endothelial Cells via the AMP-Activated Protein Kinase and FoxO1 | Q60760123 | ||
| Sodium nitroprusside inhibits N-methyl-D-aspartate-evoked calcium influx via a nitric oxide- and cGMP-independent mechanism | Q67845945 | ||
| Substrate-dependent regulation of intracellular amino acid concentrations in cultured bovine aortic endothelial cells | Q68644621 | ||
| Superoxide generation from endothelial nitric-oxide synthase. A Ca2+/calmodulin-dependent and tetrahydrobiopterin regulatory process | Q77332973 | ||
| Protein measurement with the Folin phenol reagent | Q20900776 | ||
| The AMP-activated protein kinase--fuel gauge of the mammalian cell? | Q24315074 | ||
| Thrombin activates AMP-activated protein kinase in endothelial cells via a pathway involving Ca2+/calmodulin-dependent protein kinase kinase beta | Q24670614 | ||
| Effect of supplemental oral L-arginine on exercise capacity in patients with stable angina pectoris | Q28246683 | ||
| Endothelial nitric oxide synthase in vascular disease: from marvel to menace | Q28305279 | ||
| Release of nitric oxide from endothelial cells stimulated by YC-1, an activator of soluble guanylyl cyclase | Q33179221 | ||
| Energy-sensing and signaling by AMP-activated protein kinase in skeletal muscle | Q34087151 | ||
| Galactose-1-phosphate in the pathophysiology of galactosemia | Q34721308 | ||
| Promising therapies in sickle cell disease. | Q34960390 | ||
| Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels | Q35009484 | ||
| L-arginine availability regulates T-lymphocyte cell-cycle progression | Q35628850 | ||
| Continuous exposure to L-arginine induces oxidative stress and physiological tolerance in cultured human endothelial cells | Q35874747 | ||
| Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis | Q35995063 | ||
| Pharmacokinetics of intravenous and oral L-arginine in normal volunteers | Q36053355 | ||
| Mechanism of cellular oxidation stress induced by asymmetric dimethylarginine | Q36097000 | ||
| Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages | Q36244224 | ||
| Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors | Q36253833 | ||
| Explaining the phenomenon of nitrate tolerance | Q36272905 | ||
| Arginine in the critical care setting | Q36826904 | ||
| Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells | Q37628594 | ||
| The genes of hepatic glucose metabolism | Q37932500 | ||
| Simultaneous bioanalysis of L-arginine, L-citrulline, and dimethylarginines by LC-MS/MS. | Q39600092 | ||
| Amino acids as modulators of endothelium-derived nitric oxide | Q40298583 | ||
| Partial deficiency of galactose-1-phosphate uridyltransferase | Q40480889 | ||
| Identification of nitric oxide as an endogenous activator of the AMP-activated protein kinase in vascular endothelial cells | Q41901421 | ||
| AMP-activated protein kinase mediates VEGF-stimulated endothelial NO production | Q42269153 | ||
| Effects of L-NAME, a non-specific nitric oxide synthase inhibitor, on AlCl3-induced toxicity in the rat forebrain cortex. | Q42944033 | ||
| The effect of peroxynitrite on the catalytic activity of soluble guanylyl cyclase | Q43812527 | ||
| Development of novel fluorescence probes that can reliably detect reactive oxygen species and distinguish specific species | Q44207671 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 40 | |
| P577 | publication date | 2013-05-29 | |
| P1433 | published in | Nutrition and Metabolism | Q15752980 |
| P1476 | title | AMP-activated protein kinase regulates L-arginine mediated cellular responses | |
| P478 | volume | 10 |
| Q51696769 | Benefits of L-alanine or L-arginine supplementation against adiposity and glucose intolerance in monosodium glutamate-induced obesity. |
| Q33800268 | Caffeic acid derivatives inhibit the growth of colon cancer: involvement of the PI3-K/Akt and AMPK signaling pathways |
| Q26771754 | Modulating DDAH/NOS Pathway to Discover Vasoprotective Insulin Sensitizers |
| Q33616820 | Neonatal Citrulline Supplementation and Later Exposure to a High Fructose Diet in Rats Born with a Low Birth Weight: A Preliminary Report |
Search more.